0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Voriconazole for Injection Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-14T14758
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Voriconazole for Injection Market Research Report 2023
BUY CHAPTERS

Global Voriconazole for Injection Market Research Report 2025

Code: QYRE-Auto-14T14758
Report
May 2025
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Voriconazole for Injection Market

The global market for Voriconazole for Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Voriconazole for Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Voriconazole for Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Voriconazole for Injection include Pfizer, Hainan Poly Pharm Co., Ltd., Livzon Pharmaceutical Group Inc., Beijing SL Pharmaceutical Co.,Ltd., Changjiang Runfa Health Industry Co., Ltd., Qilu Antibiotics Pharmaceutical Co., Ltd., Jiangsu Aosaikang Pharmaceutical Co., Ltd., BrightGene Bio-Medical Technology Co., Ltd., Maithili Life Sciences, Medizia Biotech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Voriconazole for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Voriconazole for Injection.
The Voriconazole for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Voriconazole for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Voriconazole for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Voriconazole for Injection Market Report

Report Metric Details
Report Name Voriconazole for Injection Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Hainan Poly Pharm Co., Ltd., Livzon Pharmaceutical Group Inc., Beijing SL Pharmaceutical Co.,Ltd., Changjiang Runfa Health Industry Co., Ltd., Qilu Antibiotics Pharmaceutical Co., Ltd., Jiangsu Aosaikang Pharmaceutical Co., Ltd., BrightGene Bio-Medical Technology Co., Ltd., Maithili Life Sciences, Medizia Biotech, Criticine Care, Eugia US, Sandoz Canada, Vinson Pharma, Alvogen, Taj Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Voriconazole for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Voriconazole for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Voriconazole for Injection Market report?

Ans: The main players in the Voriconazole for Injection Market are Pfizer, Hainan Poly Pharm Co., Ltd., Livzon Pharmaceutical Group Inc., Beijing SL Pharmaceutical Co.,Ltd., Changjiang Runfa Health Industry Co., Ltd., Qilu Antibiotics Pharmaceutical Co., Ltd., Jiangsu Aosaikang Pharmaceutical Co., Ltd., BrightGene Bio-Medical Technology Co., Ltd., Maithili Life Sciences, Medizia Biotech, Criticine Care, Eugia US, Sandoz Canada, Vinson Pharma, Alvogen, Taj Pharma

What are the Application segmentation covered in the Voriconazole for Injection Market report?

Ans: The Applications covered in the Voriconazole for Injection Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Voriconazole for Injection Market report?

Ans: The Types covered in the Voriconazole for Injection Market report are Original Drugs, Generic Drugs

Recommended Reports

Antifungal Therapeutics

Antifungal Pharmaceuticals

Injection Drug Markets

1 Voriconazole for Injection Market Overview
1.1 Product Definition
1.2 Voriconazole for Injection by Type
1.2.1 Global Voriconazole for Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 Original Drugs
1.2.3 Generic Drugs
1.3 Voriconazole for Injection by Application
1.3.1 Global Voriconazole for Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Voriconazole for Injection Market Size Estimates and Forecasts
1.4.1 Global Voriconazole for Injection Revenue 2020-2031
1.4.2 Global Voriconazole for Injection Sales 2020-2031
1.4.3 Global Voriconazole for Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Voriconazole for Injection Market Competition by Manufacturers
2.1 Global Voriconazole for Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Voriconazole for Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Voriconazole for Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Voriconazole for Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Voriconazole for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Voriconazole for Injection, Product Type & Application
2.7 Global Key Manufacturers of Voriconazole for Injection, Date of Enter into This Industry
2.8 Global Voriconazole for Injection Market Competitive Situation and Trends
2.8.1 Global Voriconazole for Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Voriconazole for Injection Players Market Share by Revenue
2.8.3 Global Voriconazole for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Voriconazole for Injection Market Scenario by Region
3.1 Global Voriconazole for Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Voriconazole for Injection Sales by Region: 2020-2031
3.2.1 Global Voriconazole for Injection Sales by Region: 2020-2025
3.2.2 Global Voriconazole for Injection Sales by Region: 2026-2031
3.3 Global Voriconazole for Injection Revenue by Region: 2020-2031
3.3.1 Global Voriconazole for Injection Revenue by Region: 2020-2025
3.3.2 Global Voriconazole for Injection Revenue by Region: 2026-2031
3.4 North America Voriconazole for Injection Market Facts & Figures by Country
3.4.1 North America Voriconazole for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Voriconazole for Injection Sales by Country (2020-2031)
3.4.3 North America Voriconazole for Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Voriconazole for Injection Market Facts & Figures by Country
3.5.1 Europe Voriconazole for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Voriconazole for Injection Sales by Country (2020-2031)
3.5.3 Europe Voriconazole for Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Voriconazole for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Voriconazole for Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Voriconazole for Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Voriconazole for Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Voriconazole for Injection Market Facts & Figures by Country
3.7.1 Latin America Voriconazole for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Voriconazole for Injection Sales by Country (2020-2031)
3.7.3 Latin America Voriconazole for Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Voriconazole for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Voriconazole for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Voriconazole for Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Voriconazole for Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Voriconazole for Injection Sales by Type (2020-2031)
4.1.1 Global Voriconazole for Injection Sales by Type (2020-2025)
4.1.2 Global Voriconazole for Injection Sales by Type (2026-2031)
4.1.3 Global Voriconazole for Injection Sales Market Share by Type (2020-2031)
4.2 Global Voriconazole for Injection Revenue by Type (2020-2031)
4.2.1 Global Voriconazole for Injection Revenue by Type (2020-2025)
4.2.2 Global Voriconazole for Injection Revenue by Type (2026-2031)
4.2.3 Global Voriconazole for Injection Revenue Market Share by Type (2020-2031)
4.3 Global Voriconazole for Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Voriconazole for Injection Sales by Application (2020-2031)
5.1.1 Global Voriconazole for Injection Sales by Application (2020-2025)
5.1.2 Global Voriconazole for Injection Sales by Application (2026-2031)
5.1.3 Global Voriconazole for Injection Sales Market Share by Application (2020-2031)
5.2 Global Voriconazole for Injection Revenue by Application (2020-2031)
5.2.1 Global Voriconazole for Injection Revenue by Application (2020-2025)
5.2.2 Global Voriconazole for Injection Revenue by Application (2026-2031)
5.2.3 Global Voriconazole for Injection Revenue Market Share by Application (2020-2031)
5.3 Global Voriconazole for Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Voriconazole for Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Voriconazole for Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Hainan Poly Pharm Co., Ltd.
6.2.1 Hainan Poly Pharm Co., Ltd. Company Information
6.2.2 Hainan Poly Pharm Co., Ltd. Description and Business Overview
6.2.3 Hainan Poly Pharm Co., Ltd. Voriconazole for Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Hainan Poly Pharm Co., Ltd. Voriconazole for Injection Product Portfolio
6.2.5 Hainan Poly Pharm Co., Ltd. Recent Developments/Updates
6.3 Livzon Pharmaceutical Group Inc.
6.3.1 Livzon Pharmaceutical Group Inc. Company Information
6.3.2 Livzon Pharmaceutical Group Inc. Description and Business Overview
6.3.3 Livzon Pharmaceutical Group Inc. Voriconazole for Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Livzon Pharmaceutical Group Inc. Voriconazole for Injection Product Portfolio
6.3.5 Livzon Pharmaceutical Group Inc. Recent Developments/Updates
6.4 Beijing SL Pharmaceutical Co.,Ltd.
6.4.1 Beijing SL Pharmaceutical Co.,Ltd. Company Information
6.4.2 Beijing SL Pharmaceutical Co.,Ltd. Description and Business Overview
6.4.3 Beijing SL Pharmaceutical Co.,Ltd. Voriconazole for Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Beijing SL Pharmaceutical Co.,Ltd. Voriconazole for Injection Product Portfolio
6.4.5 Beijing SL Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.5 Changjiang Runfa Health Industry Co., Ltd.
6.5.1 Changjiang Runfa Health Industry Co., Ltd. Company Information
6.5.2 Changjiang Runfa Health Industry Co., Ltd. Description and Business Overview
6.5.3 Changjiang Runfa Health Industry Co., Ltd. Voriconazole for Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Changjiang Runfa Health Industry Co., Ltd. Voriconazole for Injection Product Portfolio
6.5.5 Changjiang Runfa Health Industry Co., Ltd. Recent Developments/Updates
6.6 Qilu Antibiotics Pharmaceutical Co., Ltd.
6.6.1 Qilu Antibiotics Pharmaceutical Co., Ltd. Company Information
6.6.2 Qilu Antibiotics Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Qilu Antibiotics Pharmaceutical Co., Ltd. Voriconazole for Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Qilu Antibiotics Pharmaceutical Co., Ltd. Voriconazole for Injection Product Portfolio
6.6.5 Qilu Antibiotics Pharmaceutical Co., Ltd. Recent Developments/Updates
6.7 Jiangsu Aosaikang Pharmaceutical Co., Ltd.
6.7.1 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Company Information
6.7.2 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Description and Business Overview
6.7.3 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Voriconazole for Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Voriconazole for Injection Product Portfolio
6.7.5 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 BrightGene Bio-Medical Technology Co., Ltd.
6.8.1 BrightGene Bio-Medical Technology Co., Ltd. Company Information
6.8.2 BrightGene Bio-Medical Technology Co., Ltd. Description and Business Overview
6.8.3 BrightGene Bio-Medical Technology Co., Ltd. Voriconazole for Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 BrightGene Bio-Medical Technology Co., Ltd. Voriconazole for Injection Product Portfolio
6.8.5 BrightGene Bio-Medical Technology Co., Ltd. Recent Developments/Updates
6.9 Maithili Life Sciences
6.9.1 Maithili Life Sciences Company Information
6.9.2 Maithili Life Sciences Description and Business Overview
6.9.3 Maithili Life Sciences Voriconazole for Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Maithili Life Sciences Voriconazole for Injection Product Portfolio
6.9.5 Maithili Life Sciences Recent Developments/Updates
6.10 Medizia Biotech
6.10.1 Medizia Biotech Company Information
6.10.2 Medizia Biotech Description and Business Overview
6.10.3 Medizia Biotech Voriconazole for Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Medizia Biotech Voriconazole for Injection Product Portfolio
6.10.5 Medizia Biotech Recent Developments/Updates
6.11 Criticine Care
6.11.1 Criticine Care Company Information
6.11.2 Criticine Care Description and Business Overview
6.11.3 Criticine Care Voriconazole for Injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Criticine Care Voriconazole for Injection Product Portfolio
6.11.5 Criticine Care Recent Developments/Updates
6.12 Eugia US
6.12.1 Eugia US Company Information
6.12.2 Eugia US Description and Business Overview
6.12.3 Eugia US Voriconazole for Injection Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Eugia US Voriconazole for Injection Product Portfolio
6.12.5 Eugia US Recent Developments/Updates
6.13 Sandoz Canada
6.13.1 Sandoz Canada Company Information
6.13.2 Sandoz Canada Description and Business Overview
6.13.3 Sandoz Canada Voriconazole for Injection Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Sandoz Canada Voriconazole for Injection Product Portfolio
6.13.5 Sandoz Canada Recent Developments/Updates
6.14 Vinson Pharma
6.14.1 Vinson Pharma Company Information
6.14.2 Vinson Pharma Description and Business Overview
6.14.3 Vinson Pharma Voriconazole for Injection Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Vinson Pharma Voriconazole for Injection Product Portfolio
6.14.5 Vinson Pharma Recent Developments/Updates
6.15 Alvogen
6.15.1 Alvogen Company Information
6.15.2 Alvogen Description and Business Overview
6.15.3 Alvogen Voriconazole for Injection Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Alvogen Voriconazole for Injection Product Portfolio
6.15.5 Alvogen Recent Developments/Updates
6.16 Taj Pharma
6.16.1 Taj Pharma Company Information
6.16.2 Taj Pharma Description and Business Overview
6.16.3 Taj Pharma Voriconazole for Injection Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Taj Pharma Voriconazole for Injection Product Portfolio
6.16.5 Taj Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Voriconazole for Injection Industry Chain Analysis
7.2 Voriconazole for Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Voriconazole for Injection Production Mode & Process Analysis
7.4 Voriconazole for Injection Sales and Marketing
7.4.1 Voriconazole for Injection Sales Channels
7.4.2 Voriconazole for Injection Distributors
7.5 Voriconazole for Injection Customer Analysis
8 Voriconazole for Injection Market Dynamics
8.1 Voriconazole for Injection Industry Trends
8.2 Voriconazole for Injection Market Drivers
8.3 Voriconazole for Injection Market Challenges
8.4 Voriconazole for Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Voriconazole for Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Voriconazole for Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Voriconazole for Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Voriconazole for Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Voriconazole for Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Voriconazole for Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Voriconazole for Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Voriconazole for Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Voriconazole for Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Voriconazole for Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Voriconazole for Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Voriconazole for Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Voriconazole for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Voriconazole for Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Voriconazole for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Voriconazole for Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Voriconazole for Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Voriconazole for Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Voriconazole for Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Voriconazole for Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Voriconazole for Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Voriconazole for Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Voriconazole for Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Voriconazole for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Voriconazole for Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Voriconazole for Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Voriconazole for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Voriconazole for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Voriconazole for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Voriconazole for Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Voriconazole for Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Voriconazole for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Voriconazole for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Voriconazole for Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Voriconazole for Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Voriconazole for Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Voriconazole for Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Voriconazole for Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Voriconazole for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Voriconazole for Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Voriconazole for Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Voriconazole for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Voriconazole for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Voriconazole for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Voriconazole for Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Voriconazole for Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Voriconazole for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Voriconazole for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Voriconazole for Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Voriconazole for Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Voriconazole for Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Voriconazole for Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Voriconazole for Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Voriconazole for Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Voriconazole for Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Voriconazole for Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Voriconazole for Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Voriconazole for Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Voriconazole for Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Voriconazole for Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Voriconazole for Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Voriconazole for Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Voriconazole for Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Voriconazole for Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Voriconazole for Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Voriconazole for Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Voriconazole for Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Voriconazole for Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Voriconazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Voriconazole for Injection Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Hainan Poly Pharm Co., Ltd. Company Information
 Table 76. Hainan Poly Pharm Co., Ltd. Description and Business Overview
 Table 77. Hainan Poly Pharm Co., Ltd. Voriconazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Hainan Poly Pharm Co., Ltd. Voriconazole for Injection Product
 Table 79. Hainan Poly Pharm Co., Ltd. Recent Developments/Updates
 Table 80. Livzon Pharmaceutical Group Inc. Company Information
 Table 81. Livzon Pharmaceutical Group Inc. Description and Business Overview
 Table 82. Livzon Pharmaceutical Group Inc. Voriconazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Livzon Pharmaceutical Group Inc. Voriconazole for Injection Product
 Table 84. Livzon Pharmaceutical Group Inc. Recent Developments/Updates
 Table 85. Beijing SL Pharmaceutical Co.,Ltd. Company Information
 Table 86. Beijing SL Pharmaceutical Co.,Ltd. Description and Business Overview
 Table 87. Beijing SL Pharmaceutical Co.,Ltd. Voriconazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Beijing SL Pharmaceutical Co.,Ltd. Voriconazole for Injection Product
 Table 89. Beijing SL Pharmaceutical Co.,Ltd. Recent Developments/Updates
 Table 90. Changjiang Runfa Health Industry Co., Ltd. Company Information
 Table 91. Changjiang Runfa Health Industry Co., Ltd. Description and Business Overview
 Table 92. Changjiang Runfa Health Industry Co., Ltd. Voriconazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Changjiang Runfa Health Industry Co., Ltd. Voriconazole for Injection Product
 Table 94. Changjiang Runfa Health Industry Co., Ltd. Recent Developments/Updates
 Table 95. Qilu Antibiotics Pharmaceutical Co., Ltd. Company Information
 Table 96. Qilu Antibiotics Pharmaceutical Co., Ltd. Description and Business Overview
 Table 97. Qilu Antibiotics Pharmaceutical Co., Ltd. Voriconazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Qilu Antibiotics Pharmaceutical Co., Ltd. Voriconazole for Injection Product
 Table 99. Qilu Antibiotics Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 100. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Company Information
 Table 101. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Description and Business Overview
 Table 102. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Voriconazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Voriconazole for Injection Product
 Table 104. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 105. BrightGene Bio-Medical Technology Co., Ltd. Company Information
 Table 106. BrightGene Bio-Medical Technology Co., Ltd. Description and Business Overview
 Table 107. BrightGene Bio-Medical Technology Co., Ltd. Voriconazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. BrightGene Bio-Medical Technology Co., Ltd. Voriconazole for Injection Product
 Table 109. BrightGene Bio-Medical Technology Co., Ltd. Recent Developments/Updates
 Table 110. Maithili Life Sciences Company Information
 Table 111. Maithili Life Sciences Description and Business Overview
 Table 112. Maithili Life Sciences Voriconazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Maithili Life Sciences Voriconazole for Injection Product
 Table 114. Maithili Life Sciences Recent Developments/Updates
 Table 115. Medizia Biotech Company Information
 Table 116. Medizia Biotech Description and Business Overview
 Table 117. Medizia Biotech Voriconazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Medizia Biotech Voriconazole for Injection Product
 Table 119. Medizia Biotech Recent Developments/Updates
 Table 120. Criticine Care Company Information
 Table 121. Criticine Care Description and Business Overview
 Table 122. Criticine Care Voriconazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Criticine Care Voriconazole for Injection Product
 Table 124. Criticine Care Recent Developments/Updates
 Table 125. Eugia US Company Information
 Table 126. Eugia US Description and Business Overview
 Table 127. Eugia US Voriconazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Eugia US Voriconazole for Injection Product
 Table 129. Eugia US Recent Developments/Updates
 Table 130. Sandoz Canada Company Information
 Table 131. Sandoz Canada Description and Business Overview
 Table 132. Sandoz Canada Voriconazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Sandoz Canada Voriconazole for Injection Product
 Table 134. Sandoz Canada Recent Developments/Updates
 Table 135. Vinson Pharma Company Information
 Table 136. Vinson Pharma Description and Business Overview
 Table 137. Vinson Pharma Voriconazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Vinson Pharma Voriconazole for Injection Product
 Table 139. Vinson Pharma Recent Developments/Updates
 Table 140. Alvogen Company Information
 Table 141. Alvogen Description and Business Overview
 Table 142. Alvogen Voriconazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Alvogen Voriconazole for Injection Product
 Table 144. Alvogen Recent Developments/Updates
 Table 145. Taj Pharma Company Information
 Table 146. Taj Pharma Description and Business Overview
 Table 147. Taj Pharma Voriconazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Taj Pharma Voriconazole for Injection Product
 Table 149. Taj Pharma Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Voriconazole for Injection Distributors List
 Table 153. Voriconazole for Injection Customers List
 Table 154. Voriconazole for Injection Market Trends
 Table 155. Voriconazole for Injection Market Drivers
 Table 156. Voriconazole for Injection Market Challenges
 Table 157. Voriconazole for Injection Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Voriconazole for Injection
 Figure 2. Global Voriconazole for Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Voriconazole for Injection Market Share by Type: 2024 & 2031
 Figure 4. Original Drugs Product Picture
 Figure 5. Generic Drugs Product Picture
 Figure 6. Global Voriconazole for Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Voriconazole for Injection Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Other
 Figure 11. Global Voriconazole for Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Voriconazole for Injection Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Voriconazole for Injection Sales (2020-2031) & (K Units)
 Figure 14. Global Voriconazole for Injection Average Price (US$/Unit) & (2020-2031)
 Figure 15. Voriconazole for Injection Report Years Considered
 Figure 16. Voriconazole for Injection Sales Share by Manufacturers in 2024
 Figure 17. Global Voriconazole for Injection Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Voriconazole for Injection Players: Market Share by Revenue in Voriconazole for Injection in 2024
 Figure 19. Voriconazole for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Voriconazole for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Voriconazole for Injection Sales Market Share by Country (2020-2031)
 Figure 22. North America Voriconazole for Injection Revenue Market Share by Country (2020-2031)
 Figure 23. United States Voriconazole for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Voriconazole for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Voriconazole for Injection Sales Market Share by Country (2020-2031)
 Figure 26. Europe Voriconazole for Injection Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Voriconazole for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Voriconazole for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Voriconazole for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Voriconazole for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Voriconazole for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Voriconazole for Injection Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Voriconazole for Injection Revenue Market Share by Region (2020-2031)
 Figure 34. China Voriconazole for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Voriconazole for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Voriconazole for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Voriconazole for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Voriconazole for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Voriconazole for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Voriconazole for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Voriconazole for Injection Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Voriconazole for Injection Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Voriconazole for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Voriconazole for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Voriconazole for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Voriconazole for Injection Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Voriconazole for Injection Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Voriconazole for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Voriconazole for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Voriconazole for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Voriconazole for Injection by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Voriconazole for Injection by Type (2020-2031)
 Figure 53. Global Voriconazole for Injection Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Voriconazole for Injection by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Voriconazole for Injection by Application (2020-2031)
 Figure 56. Global Voriconazole for Injection Price (US$/Unit) by Application (2020-2031)
 Figure 57. Voriconazole for Injection Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS